GSK's GSK +0.59% Get Free Report short percent of float has fallen 27.17% since its last report. The company recently reported that it has 13.51 million shares sold short, which is 0.67% of all ...

A friendly red panda avatar serves up the knowledge from the organization's own siloed databases, complete with citations ...

Google DeepMind unveils AlphaEarth Foundations, an AI system that processes satellite data 16x more efficiently to create ...

British stocks displayed slight fluctuations amid mixed corporate earnings and trade speculations. The FTSE 100 remained ...

Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.

GSK PLC GSK shares rose 4.69% to £14.63 Wednesday, on what proved to be an all-around favorable trading session for the stock ...

With a portfolio of 14 potential blockbuster treatments that it expects to launch over the next five years, GSK is sticking ...

GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

GSK anticipates high sales and profit growth in 2025 after surpassing second-quarter forecasts, while addressing U.S. tariffs ...